These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5341162)

  • 1. The effect of a new potent antifibrinolytic agent, tranexamic acid.
    Kobayashi T; Sugiura J
    J Jpn Obstet Gynecol Soc; 1966 Jul; 13(3):158-67. PubMed ID: 5341162
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
    Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
    Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M; Sieg U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
    Avanzi G
    Minerva Med; 1972 Dec; 63(87):4758-66. PubMed ID: 4565687
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the treatment of obstetrical and gynecological bleedings with a new anti-fibrinolytic agent].
    Harms W
    Med Welt; 1968 Mar; 10():643-51. PubMed ID: 5706212
    [No Abstract]   [Full Text] [Related]  

  • 7. The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
    Koutský J; Rybák M; Jirásek JE; Hladovec J; Mansfeld V
    Gynaecologia; 1969; 167(4):265-70. PubMed ID: 5767879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of antifibrinolytic agents in obstetrics].
    Vojta M
    Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of obstetric bleeding with antifibrinolytics.
    Isaksson G
    Cent Afr J Med; 1973 May; 19(5):98. PubMed ID: 4541738
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical applications of the antiprogestins.
    Kettel LM
    Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic activity of peripheral and uterine blood as influenced by p-aminomethylbenzoic acid (PAMBA) in pgnancy toxemias].
    Sieg U; Flähmig M
    Zentralbl Gynakol; 1969 Dec; 91(51):1662-6. PubMed ID: 5383534
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of tranexamic acid (AMCA) on postoperative bleeding after conization.
    Rybo G; Westerberg H
    Acta Obstet Gynecol Scand; 1972; 51(4):347-50. PubMed ID: 4566005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of gynecological bleeding using antifibrinolytic agents].
    Koutský J; Padovec J; Dimitrovová K; Mansfeld V; Kastilová B; Rybák M
    Cesk Gynekol; 1967 Aug; 32(6):429-32. PubMed ID: 5584227
    [No Abstract]   [Full Text] [Related]  

  • 14. A double blind study of the effect of tranexamic acid in essential menorrhagia.
    Vermylen J; Verhaegen-Declercq ML; Fierens F; Verstraete M
    Bull Soc R Belge Gynecol Obstet; 1968; 38(5):385-90. PubMed ID: 4890296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gossypol treatment for menopausal functional bleeding, myoma of uterus and endometriosis--preliminary report (author's transl)].
    Han HL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Sep; 2(3):167-70. PubMed ID: 6451316
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pattern of fibrinolytic disorders in uterine blood and the effect of PAMBA]].
    Flähmig M; Sieg U; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):41-50. PubMed ID: 4173879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolytic hemorrhages and their treatment by p-aminomethylbenzoic acid].
    Sundermann A
    Verh Dtsch Ges Inn Med; 1965; 71():749-53. PubMed ID: 5298271
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
    Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of clinical experiments with a new antifibrinolytic agent para-amino-methylbenzoic acid (PAMBA)].
    Sundermann A; Vogel G
    Pol Tyg Lek; 1967 Jan; 22(1):11-4. PubMed ID: 5341436
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata.
    Chwalisz K; DeManno D; Garg R; Larsen L; Mattia-Goldberg C; Stickler T
    Semin Reprod Med; 2004 May; 22(2):113-9. PubMed ID: 15164306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.